Finance

Lists
B1SX34:BVMF
Boston Scientific Corp Brazilian Depositary Receipt
R$64.25
+0.34%
(+0.22) 1D
Nov 19, 5:53:47 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for B1SX34...
Open
R$64.03
High
R$64.35
Low
R$63.61
Mkt. cap
60.85B
Avg. vol.
1.00K
Volume
0.00
52-wk high
R$136.34
52-wk low
R$50.29
Shares outstanding
1.45B
No. of employees
59K
Open
R$64.03
High
R$64.35
Low
R$63.61
Mkt. cap
60.85B
Avg. vol.
1.00K
Volume
0.00
52-wk high
R$136.34
52-wk low
R$50.29
Shares outstanding
1.45B
No. of employees
59K
News stories
From web sources and news partners
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for developing the Taxus Stent, a drug-eluting stent that is used to open clogged arteries. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp Brazilian Depositary Receipt
CEOMichael F. Mahoney
Employees59K
FoundedJun 29, 1979
HeadquartersMarlborough, Massachusetts, United States
SectorHealth Care
IndustryMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.29B
5.20B
5.44B
5.14B
Cost of goods sold
1.61B
1.60B
1.61B
1.72B
Cost of revenue
1.61B
1.60B
1.61B
1.72B
Research and development expenses
569.00M
516.00M
554.00M
520.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.83B
1.78B
1.80B
1.68B
Operating expense
2.63B
2.53B
2.59B
2.44B
Total operating expenses
4.24B
4.13B
4.20B
4.16B
Operating income
1.04B
1.07B
1.25B
979.00M
Other non operating income
28.00M
28.00M
-6.00M
-18.00M
EBT including unusual items
700.00M
1.16B
1.06B
733.00M
EBT excluding unusual items
1.01B
999.00M
1.14B
848.00M
Income tax expense
30.00M
-176.00M
155.00M
153.00M
Effective tax rate
4.29%
-15.13%
14.62%
20.87%
Other operating expenses
-
-
-
-
Net income
672.00M
1.34B
907.00M
582.00M
Net profit margin
12.71%
25.77%
16.67%
11.33%
Earnings per share
0.80
0.80
0.86
0.73
Interest and investment income
29.00M
-
11.00M
-
Interest expense
-90.00M
-90.00M
-96.00M
-100.00M
Net interest expenses
-61.00M
-90.00M
-85.00M
-100.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.41B
1.42B
1.60B
1.34B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps